Magnesium oxide tablets form rigid masses in xanthan gum-based thickeners: A physicochemical hazard revealed by a clinical case.

PLoS OneOct 29, 2026 (epub)

Soichi Makino, Miyu Ooe, Kazunari Miyazawa et al.

✦ AI-curated · Sources linked

Case in brief

An older adult with a malignant esophageal stricture developed acute esophageal obstruction from a foreign body identified as a swollen, non-disintegrated magnesium oxide (MgO) tablet. Ex vivo imaging and chemical analysis supported the identification. In a static immersion model, all four tested MgO formulations failed to disintegrate in every tested combination with xanthan gum-based thickeners; at 2.0–3.0% thickener, tablet weight increased by approximately 2.2-fold and rigid masses formed. The tablets disintegrated in swallowing-aid jelly in approximately 25 s, but it cost approximately 14.5-fold more per administration than thickeners.

What made this case unusual

The obstruction was linked to a physicochemical interaction: xanthan gum-based thickener prevented MgO tablet disintegration and produced a swollen, rigid mass, a hazard that may be overlooked when thickened fluids are treated as inert swallowing aids.

Diagnostic / clinical pearl

In a patient with dysphagia and esophageal obstruction, consider a medication–thickener interaction. Xanthan gum-based thickeners prevented disintegration of all tested MgO formulations in the study’s immersion model.

Why it matters

The reported cost difference—swallowing-aid jelly was approximately 14.5-fold more expensive per administration—may be a barrier to adopting an alternative vehicle, despite the potential mechanical hazard.

Source

Published in PLoS One. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.